Pfizer and AstraZeneca COVID-19 vaccines are ‘highly effective’ against India variant

Vaccine effectiveness against symptomatic disease from the B.1.617.2 (‘India’) variant is similar to that found against the B.1.1.7 ('UK') variant, according to a new study.